Key facts
- It has raised $100.2M across 4 recorded rounds; the latest was PIPE ($100.2M) in Oct 2023.
- Harpoon Therapeutics has filed 4 Form Ds with the SEC since 2017, most recently Oct 2023 ($100.2M sold to 18 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Harpoon Therapeutics
Create free account
No card required
Funding rounds
4 roundsOct 2023PIPE$100.2M▮
About Harpoon Therapeutics
- Industry
- Drug Discovery
PA Mark — not yet priced
Harpoon Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Harpoon Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Harpoon Therapeutics in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.